Here is a review of the issue with second-quarter additional doses of the Pfizer vaccine. Note that the discussions happened after the efficacy was already demonstrated, albeit while awaiting safety data.
"This has been a challenging process because there have been multiple conversations happening as recently as November," Dr. Scott Gottlieb told CNBC.
www.cnbc.com
It's notable the "pass" on these doses was after Trump lost the election. Almost like he wanted to cause a disruption after Biden takes office.
We will see how it plays out. Here is part of the article:
"There were multiple conversations with the U.S. government about taking more supply in the second quarter. The company wasn't taken up on that offer, as recently as November," Gottlieb said on "Squawk Box."
(Snip)
Gottlieb, the former FDA chief under President Donald Trump, first indicated last week that the U.S. government had declined to exercise the option in its agreement with Pfizer for additional vaccine doses. He told CNBC that Pfizer offered the U.S. doses from its Michigan manufacturing plant for the second quarter of 2021. The company is already sending the U.S. all of its first-quarter supply from that plant, he said."
(Snip)
Pfizer has since entered into agreements with other countries for its second-quarter allotment of vaccine doses, Gottlieb said Monday. However, he expressed optimism that the company and the U.S. government will be able to strike a deal to acquire more doses.
Sent from my ONEPLUS A6013 using Tapatalk
